The CEO's $51.8M post-earnings sale is large in absolute terms but trivial relative to market cap (0.13%). Given the strong fundamental backdrop (raised guidance, accelerating profitability), these sales are likely diversification. Monitor for any follow-on sales in the next 30 days, a continued pattern would increase bearish weight.
ONC drugs
ONC drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 13 $356.01entry
- T+1 · 3mo ago −2.40%α −2.20% · $347.48
- T+5 · 3mo ago +3.69%α +5.66% · $369.16
- T+20 · 2mo ago −2.67%α −0.92% · $346.51
- T+60 · 11d ago +14.85%α +20.09% · $408.89
Price Chart
How similar events traded
Executive Summary
CEO John Oyler sold ~$51.8M worth of ONC shares over three days (Aug 10-12), and CFO Aaron Rosenberg sold $362K on Aug 3, all open-market sales. This cluster follows a strong Q2 earnings beat (revenue +30% YoY, raised guidance) reported 7 days prior. While the sales are large in absolute terms ($52.2M total), they represent only ~0.13% of the $40.8B market cap, below the 0.5% threshold for materiality. The CEO's sales are concentrated and not part of a visible 10b5-1 pattern, but the post-earnings timing and modest proportionality suggest liquidity/diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- CEO John Oyler sold ~$51.8M in open-market sales over Aug 10-12, 2026 across 20 trades at prices $350-$367
- CFO Aaron Rosenberg sold $362K on Aug 3, 2026 at $312.71
- Total cluster value of ~$52.2M represents ~0.13% of ONC's $40.8B market cap
- Sales follow a strong Q2 2026 earnings beat (revenue $1.71B, +30% YoY; raised FY guidance to $6.6B-$6.8B) reported 7 days prior
- No visible 10b5-1 plan pattern; sales are concentrated in a 3-day window for the CEO
Financial Impact
CEO sold ~$51.8M (0.13% of market cap); CFO sold $362K (negligible)
Risk Factors
- CEO sold ~$51.8M without a disclosed 10b5-1 plan, which could signal personal conviction concerns if sales continue
- Concentrated 3-day selling window by the CEO may indicate a planned exit program not yet disclosed
- Post-earnings insider selling, even if modest relative to cap, can weigh on sentiment in a stock up ~15% over the past 2 months
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ONC-1786572082787 |
Track record
27 reports on ONC
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $416.54 +0.00% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $416.54 −0.82% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $416.54 −0.19% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $416.54 +2.35% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $416.54 +7.56% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $416.54 +10.26% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $416.54 −15.18% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $416.54 +13.17% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $416.54 +20.21% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $416.54 +16.27% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers